'On consolidated basis
Quarter ended March 2025 compared with Quarter ended March 2024.
Net sales (including other operating income) of Natco Pharma has increased 14.29% to Rs 1221 crore. Sales of Pharmaceutical segment has gone up 12.23% to Rs 1,206.00 crore (accounting for 98.77% of total sales).
Profit before interest, tax and other unallocable items (PBIT) has jumped 6.68% to Rs 516.10 crore. PBIT of Pharmaceutical segment rose 11.21% to Rs 597.00 crore (accounting for 115.68% of total PBIT). PBIT of Agro Chemical segment fell 52.64% to Rs -80.90 crore (accounting for -15.68% of total PBIT).
PBIT margin of Pharmaceutical segment fell from 49.95% to 49.50%. PBIT margin of Agro Chemical segment fell from 841.27% to 539.33%. Overall PBIT margin fell from 45.29% to 42.27%.
Operating profit margin has declined from 46.55% to 44.89%, leading to 10.22% rise ...
Pleaselogin & subscribe to view the full report.
More Reports
|
|